Literature DB >> 3013348

8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer.

M E Lippman, R B Dickson, S Bates, C Knabbe, K Huff, S Swain, M McManaway, D Bronzert, A Kasid, E P Gelmann.   

Abstract

We consider the hypothesis that estrogen control of hormone dependent breast cancer is mediated by autocrine and paracrine growth factors secreted by the breast cancer cells themselves. Though we show direct, unmediated effects of estrogen on specific cell functions, we also provide evidence that human breast cancer cells secrete a collection of growth factors (IGF-I, TGF alpha, TGF beta, a PDGF-like competency factor, and at least one new epithelial colony stimulating factor). Some of these are estrogen-regulated in hormone dependent cells, and are constitutively increased in cells which acquire independence either spontaneously or by ras transfection. Collectively, the secreted growth factors are capable of promoting tumor formation by MCF-7 cells in nude mice, though not to the same extent as estrogens. There would seem to be potential for clinical intervention in the autocrine and paracrine control of breast cancer cells, including some cells which are no longer dependent on estrogens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013348     DOI: 10.1007/bf01806790

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  53 in total

1.  Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.

Authors:  K Seibert; S M Shafie; T J Triche; J J Whang-Peng; S J O'Brien; J H Toney; K K Huff; M E Lippman
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

2.  Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7.

Authors:  M J Page; J K Field; N P Everett; C D Green
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

3.  Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line.

Authors:  C Natoli; G Sica; V Natoli; A Serra; S Iacobelli
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

4.  Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture.

Authors:  K K Huff; M E Lippman
Journal:  Endocrinology       Date:  1984-05       Impact factor: 4.736

5.  A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization.

Authors:  M E Lippman; J Cassidy; M Wesley; R C Young
Journal:  J Clin Oncol       Date:  1984-01       Impact factor: 44.544

6.  Purification and properties of a mammary-uterine-pituitary tumor cell growth factor from pregnant sheep uterus.

Authors:  T Ikeda; D A Sirbasku
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

7.  Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer.

Authors:  D P Edwards; S R Murthy; W L McGuire
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

8.  Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.

Authors:  B S Katzenellenbogen; M J Norman; R L Eckert; S W Peltz; W F Mangel
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

9.  Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells.

Authors:  K H Cowan; M E Goldsmith; R M Levine; S C Aitken; E Douglass; N Clendeninn; A W Nienhuis; M E Lippman
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

10.  Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.

Authors:  G Carpenter; C M Stoscheck; Y A Preston; J E DeLarco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

View more
  38 in total

Review 1.  Biochemical study of cyst fluid in human breast cystic disease: a review.

Authors:  C L Enriori; J E Novelli; M del C Cremona; R J Hirsig; P J Enriori
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies.

Authors:  N Falette; M F Lefebvre; F Meggouh; M Eynard; E Garin; S Saez
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

3.  Effects of human breast fibroblasts on growth and 17 beta-estradiol dehydrogenase activity of MCF-7 cells in culture.

Authors:  E F Adams; C J Newton; H Braunsberg; N Shaikh; M Ghilchik; V H James
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

4.  Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.

Authors:  J D Jacquemier; J Hassoun; M Torrente; P M Martin
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

5.  Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture.

Authors:  L Rønnov-Jessen; B Van Deurs; M Nielsen; O W Petersen
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

6.  A 23-pS Ca2(+)-activated K+ channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cell proliferation.

Authors:  E A Wegman; J A Young; D I Cook
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

7.  Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).

Authors:  B L Nguyen; G Chetrite; J R Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

8.  Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes.

Authors:  S Batra
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.

Authors:  C Charpin; B Devictor; P Bonnier; L Andrac; M N Lavaut; C Allasia; L Piana
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Growth factor expression in normal, benign, and malignant breast tissue.

Authors:  M T Travers; P J Barrett-Lee; U Berger; Y A Luqmani; J C Gazet; T J Powles; R C Coombes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.